Efficacy in Myopia Control: The Low-Concentration Atropine for Myopia Progression (LAMP) Study. | Ophthalmology;130(7): 771-772, 2023 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Brasil - Virtual Health Library

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Efficacy in Myopia Control: The Low-Concentration Atropine for Myopia Progression (LAMP) Study.

Bullimore, Mark A; Brennan, Noel A.

Affiliation

Bullimore MA; University of Houston, College of Optometry, Houston, Texas. Electronic address: bullers2020@gmail.com.
Brennan NA; Johnson & Johnson Vision, Jacksonville, Florida.

Ophthalmology ; 130(7): 771-772, 2023 Jul.

Article in En | MEDLINE | ID: mdl-36842480

Subject(s)

Atropine; Myopia; Humans; Myopia/drug therapy; Mydriatics; Ophthalmic Solutions; Disease Progression; Refraction, Ocular

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atropine / Myopia Limits: Humans Language: En Journal: Ophthalmology Year: 2023 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atropine / Myopia Limits: Humans Language: En Journal: Ophthalmology Year: 2023 Document type: Article